---
document_datetime: 2026-02-18 11:20:48
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/pluvicto-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: pluvicto-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 2.6685599
conversion_datetime: 2026-02-21 13:09:03.219142
docling_version:
  docling-serve: 1.13.0
  docling-jobkit: 1.11.0
  docling: 2.74.0
  docling-core: 2.65.1
  docling-ibm-models: 3.11.0
  docling-parse: 5.3.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.3-arm64-arm-64bit-Mach-O
---
## Pluvicto

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                       |
|----------------------|----------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------------------------------------------|
| Variation type IB /  | C. Safety, efficacy, pharmacovigilance | 17/02/2026                          |                                             | SmPC                             | To update Section 11 (Table 4) of the SmPC to |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000325276                     | changes - C.z Other variation - Accepted C.z (Type IB) - To update Section 11 (Table 4) of the SmPC to correct the dosimetry data.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |            | correct the dosimetry data.   |
|---------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-------------------------------|
| Variation type IA / EMA/VR/0000320510 | B.III.2 Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - B.III.2.b Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State - Accepted                                                                                                                                                                                                                                                                                                                                                                                          | 06/01/2026 |                               |
| Variation type IB / EMA/VR/0000309381 | This was an application for a group of variations. B.I.a.3 Change in batch size (including batch size ranges) of active substance or intermediate used in the manufacturing process of the active substance - B.I.a.3.z Other variation - Accepted B.I.a.4 Change to in-process tests or limits applied during the manufacture of the active substance - B.I.a.4.z Other variation - Accepted B.I.b.2 Change in test procedure for active substance or starting material/reagent/intermediate used in the manufacturing process of the active substance - B.I.b.2.e Other changes to a test procedure (including replacement or | 26/11/2025 |                               |

<div style=\"page-break-after: always\"></div>

|                     | starting material/intermediate - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |            |    |                   |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|----|-------------------|
| Article 61(3) /     | - Notification acc. Article 61(3) - Accepted Update of the package leaflet with revised contact details of local representative.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 17/10/2025 | PL | EMA/N/0000306844  |
| Variation type II / | B.I.b.1 Change in the specification parameters and/or limits of an active substance, starting material / intermediate / reagent used in the manufacturing process of the active substance - B.I.b.1.f Change outside the approved specifications limits range for the active substance - Accepted B.I.b.1 Change in the specification parameters and/or limits of an active substance, starting material / intermediate / reagent used in the manufacturing process of the active substance - B.I.b.1.c Addition of a new specification parameter to the specification with its corresponding test method - Accepted B.I.b.2 Change in test procedure for active substance or starting material/reagent/intermediate used in the manufacturing process of the active substance - B.I.b.2.a Minor changes to an approved test procedure - Accepted | 18/09/2025 |    | EMA/VR/0000285067 |

<div style=\"page-break-after: always\"></div>

| Article 61(3) / EMA/N/0000257727   | - - Accepted Update of the package leaflet with revised contact details of local representatives.                                 | 25/03/2025   | PL   |             |
|------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------|--------------|------|-------------|
| Article 61(3) / EMA/N/0000244915   | - Notification acc. Article 61(3) - Accepted Update of the package leaflet with revised contact details of local representatives. | 10/02/2025   | PL   |             |
| PSUR / EMA/PSUR/0000282271         |                                                                                                                                   |              |      | Maintenance |